Geftinat 250 Mg Tablets

Description

Introduction to Geftinat Gefitinib 250 mg Tablet Geftinat 250mg Tablet is a medicine used to treat non-small cell lung cancer (NSCLC). It is beneficial for patients with a specific mutation in the epidermal growth factor receptor (EGFR) gene. Geftinat 250mg Tablet, manufactured by Natco Pharma Ltd., is a generic version of the well-known brand Iressa. Gefitinib Medication works best for people whose cancer has spread to other parts of the body and who havent had cancer treatments before. Geftinat targets proteins that slow or stop tumor growth. How Does Geftinat Work? Gefitinib mechanism of action : Geftinat 250 contains the active ingredient gefitinib, which blocks the activity of the EGFR protein. EGFR is crucial for cell growth and repair; however, when mutated, it becomes overactive, leading to rapid cancer cell proliferation. Geftinat blocks EGFR signaling, reducing the signals that tell cancer cells to grow and spread. This makes the drug especially effective for treating cancers with EGFR mutations, helping control the disease even when it has spread beyond the lungs. Uses of Geftinat 250mg Geftinat 250mg Tablet is mainly used to: Treat Non-Small Cell Lung Cancer (NSCLC): It is effective in patients with specific EGFR mutations, making it a targeted and effective treatment option. Dosage and How to Take the Geftinat Tablet Take one Geftinat 250mg tablet daily or as instructed by your doctor. Swallow the tablet whole with water. Do not crush, chew, or break it, as it is designed to release the medicine slowly and evenly. Take Geftinat with or without food, but try to take it at the same time every day to keep the medicine levels steady in your body. Side Effects of Geftinat 250 mg Tablet Geftinat is effective, but like all medicines, it can cause side effects. Common Side Effects: Nausea and vomiting Diarrhea Loss of appetite Rash or dry skin Feeling tired Serious Side Effects: Severe breathing problems Liver issues (e.g., yellowing of the skin or eyes) Severe diarrhea or stomach pain Swelling in the hands or feet Precautions While Using Geftinat Do not take Geftinat Tablet if you are pregnant, as it may harm the baby. Avoid taking Geftinat 250mg while breastfeeding. Refrain from consuming alcohol, as it may increase the risk of side effects associated with Geftinat Gefitinib 250mg Tablet. Please do not smoke while taking Geftinat, as it can reduce the effectiveness of the medicine. Geftinat may cause dizziness or fatigue; avoid activities that require alertness if these symptoms occur. Consult your doctor before taking this medication if you have liver or kidney issues. Avoid drinking grapefruit juice while taking Gefitinib, as it may alter the way the medicine works. Drug Interactions Geftinat can interact with other medicines or foods: Medications: Avoid taking Geftinat with antacids, blood thinners, or other cancer drugs, as these may interfere with its effectiveness. Warning: Always consult the patient’s doctor before taking Geftinat (Gefitinib) 250mg Tablet. Geftinat vs Iressa Feature Geftinat (Gefitinib 250mg) Iressa (Gefitinib 250mg) Active Ingredient Gefitinib Gefitinib Drug Class EGFR Tyrosine Kinase Inhibitor EGFR Tyrosine Kinase Inhibitor Indication Non-small cell lung cancer (NSCLC) with EGFR mutations Non-small cell lung cancer (NSCLC) with EGFR mutations Mechanism of Action Inhibits EGFR tyrosine kinase, blocking cancer growth Inhibits EGFR tyrosine kinase, blocking cancer growth FDA Approval Status Generic, not individually FDA-approved FDA-approved as the branded version of Gefitinib Manufacturer Natco Pharma Ltd. AstraZeneca Cost More affordable, widely available in generic markets Higher cost as a branded medication Availability Widely available as a generic Available globally as a branded drug Unique Features Cost-effective alternative to Iressa Original branded version with extensive clinical trial data